Johnson & Johnson Q2 FY2026 Earnings Call

Johnson & Johnson (JNJ)

Earnings Call FY2026 Q2 Call date: 2025-10-14 Concluded

Quarter scorecard

Revenue

$23.74B

+5.8% YoY

Diluted EPS

$2.29

+18.7% YoY

Gross margin

67.9%

-1.5 pp YoY

Net income

$5.54B

+18.2% YoY

Innovative Medicine $15.20B

+4.9%

MedTech $8.54B

+7.3%

Buybacks (derived)

Dividend / share

$1.30

ex Nov 25